Physician profile
Stephen C Jones
NPI 1285664722
$1,027.16
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $112 · 2021: $355 · 2022: $365 · 2023: $94.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $296.83 | 2019-2022 | |
| Avion Pharmaceuticals | $207.82 | 2019-2022 | |
| Organon LLC | $99.97 | 2021-2023 | Nexplanon |
| Aspira Women'S Health INC | $93.20 | 2022 | |
| Mylan Pharmaceuticals INC. | $54.41 | 2021-2022 | |
| Daiichi Sankyo INC. | $46.78 | 2021-2022 | |
| Optumhealth Care Solutions, LLC | $39.87 | 2023 | Vivify Health Care Team Portal |
| Astellas Pharma US INC | $27.93 | 2023 | Veozah, Myrbetriq |
| Upsher-Smith Laboratories LLC | $24.42 | 2020 | |
| Scynexis, INC. | $20.80 | 2022 | |
| Sanara Medtech INC. | $16.28 | 2020 | |
| Pfizer INC. | $15.93 | 2022 | |
| Therapeuticsmd, INC. | $15.86 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.64 | 2019 | |
| Evofem Biosciences, INC. | $14.00 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.18 | 2019 | |
| Minerva Surgical, INC | $12.79 | 2021 | |
| Agile Therapeutics, INC. | $11.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.